446 related articles for article (PubMed ID: 14689352)
21. TB prevention in HIV clinics in New York City.
Sackoff JE; Torian LV; Frieden TR
Int J Tuberc Lung Dis; 2001 Feb; 5(2):123-8. PubMed ID: 11258505
[TBL] [Abstract][Full Text] [Related]
22. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
[TBL] [Abstract][Full Text] [Related]
23. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis.
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199
[TBL] [Abstract][Full Text] [Related]
24. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).
Tangüis HG; Caylà JA; García de Olalla PG; Jansà JM; Brugal MT
Int J Tuberc Lung Dis; 2000 Jan; 4(1):55-60. PubMed ID: 10654645
[TBL] [Abstract][Full Text] [Related]
25. Impact of drug-resistant tuberculosis on the survival of HIV-infected patients.
Sungkanuparph S; Eampokalap B; Chottanapund S; Thongyen S; Manosuthi W
Int J Tuberc Lung Dis; 2007 Mar; 11(3):325-30. PubMed ID: 17352100
[TBL] [Abstract][Full Text] [Related]
26. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy.
Selwyn PA; Sckell BM; Alcabes P; Friedland GH; Klein RS; Schoenbaum EE
JAMA; 1992 Jul 22-29; 268(4):504-9. PubMed ID: 1619742
[TBL] [Abstract][Full Text] [Related]
27. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.
Hiransuthikul N; Hanvanich M; Dore GJ; Mokkhawes T; Li Y; Perriens J; Kaldor JM
Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):804-9. PubMed ID: 15115092
[TBL] [Abstract][Full Text] [Related]
29. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
[TBL] [Abstract][Full Text] [Related]
31. HIV infection-related tuberculosis: clinical manifestations and treatment.
Sterling TR; Pham PA; Chaisson RE
Clin Infect Dis; 2010 May; 50 Suppl 3():S223-30. PubMed ID: 20397952
[TBL] [Abstract][Full Text] [Related]
32. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
[TBL] [Abstract][Full Text] [Related]
33. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
Hartel DM; Schoenbaum EE
Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
[TBL] [Abstract][Full Text] [Related]
34. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.
Kalou M; Sassan-Morokro M; Abouya L; Bile C; Maurice C; Maran M; Tossou O; Roels T; Greenberg AE; Wiktor SZ; Nkengasong JN
J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734
[TBL] [Abstract][Full Text] [Related]
35. INH preventive therapy among adult HIV-infected patients in Thailand.
Hiransuthikul N; Nelson KE; Hiransuthikul P; Vorayingyong A; Paewplot R
Int J Tuberc Lung Dis; 2005 Mar; 9(3):270-5. PubMed ID: 15786889
[TBL] [Abstract][Full Text] [Related]
36. Crack cocaine use and other risk factors for tuberculin positivity in drug users.
Howard AA; Klein RS; Schoenbaum EE; Gourevitch MN
Clin Infect Dis; 2002 Nov; 35(10):1183-90. PubMed ID: 12410478
[TBL] [Abstract][Full Text] [Related]
37. Mycobacterium tuberculosis infection in pregnant and nonpregnant women infected with HIV in the Women and Infants Transmission Study.
Mofenson LM; Rodriguez EM; Hershow R; Fox HE; Landesman S; Tuomala R; Diaz C; Daniels E; Brambilla D
Arch Intern Med; 1995 May; 155(10):1066-72. PubMed ID: 7748050
[TBL] [Abstract][Full Text] [Related]
38. Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.
Mohammed A; Myer L; Ehrlich R; Wood R; Cilliers F; Maartens G
Int J Tuberc Lung Dis; 2007 Oct; 11(10):1114-20. PubMed ID: 17945069
[TBL] [Abstract][Full Text] [Related]
39. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
Marais BJ; Graham SM; Cotton MF; Beyers N
J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
